Iboxx $ High Yield Cor (HYG.US)

Close: 76.81 (+0.09), May 13, 2022
Negative

Low risk

Automatic technical analysis. Medium term, May 13, 2022

Iboxx $ High Yield Corporate Bd Ishares has broken the falling trend channel down in the medium long term, which indicates an even stronger falling rate. There is no support in the price chart and further decline is indicated. In case of a positive reaction, the stock has resistance at 82.70 dollar. Volume has previously been low at price tops and high at price bottoms. This confirms the trend. The stock is overall assessed as technically negative for the medium long term.

Recommendation one to six months: Negative (Score: -92)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.28%3 770.17+0.12%
5 days63.950.85%3 496.88-1.01%
22 days4.621.98%3 031.85-4.35%
66 days-0.103.42%3 397.26-8.14%

More analyses of Iboxx $ High Yield Corporate Bd Ishares

chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Candlesticks 22 Days
Candlesticks
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Short term
Short term: Negative
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Medium term
Medium term: Negative
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+